5‐Methoxy‐ <i>N</i> , <i>N</i> ‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial
Year: 2025
Type: article
Language: en
Topic: Substance Abuse Treatment and Outcomes
Authors and affiliations:
raw_author_name: John Marsden
raw_affiliation_strings: Addictions Department, School of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience King's College London  London UK
South London and Maudsley NHS Foundation Trust  UK
South London and Maudsley NHS Foundation Trust, UK
Addictions Department, School of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
raw_author_name: Michael Kelleher
raw_affiliation_strings: Addictions Department, School of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience King's College London  London UK
South London and Maudsley NHS Foundation Trust  UK
Addictions Department, School of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
South London and Maudsley NHS Foundation Trust, UK
raw_author_name: Fiona Dunbar
raw_affiliation_strings: Beckley Psytech  Oxford UK
Beckley Psytech, Oxford, UK
raw_author_name: Anna O. Ermakova
raw_affiliation_strings: Beckley Psytech  Oxford UK
Beckley Psytech, Oxford, UK
raw_author_name: Luke Mitcheson
raw_affiliation_strings: Addictions Department, School of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience King's College London  London UK
South London and Maudsley NHS Foundation Trust  UK
South London and Maudsley NHS Foundation Trust, UK
Addictions Department, School of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
raw_author_name: Claire Roberts
raw_affiliation_strings: Beckley Psytech  Oxford UK
Beckley Psytech, Oxford, UK
raw_author_name: James J. Rucker
raw_affiliation_strings: Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience King's College London  London UK
South London and Maudsley NHS Foundation Trust  UK
South London and Maudsley NHS Foundation Trust, UK
Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
raw_author_name: Gemma Scott
raw_affiliation_strings: South London and Maudsley NHS Foundation Trust  UK
South London and Maudsley NHS Foundation Trust, UK
raw_author_name: Ivan Saeger
raw_affiliation_strings: South London and Maudsley NHS Foundation Trust  UK
South London and Maudsley NHS Foundation Trust, UK
raw_author_name: Francesca Small
raw_affiliation_strings: Addictions Department, School of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience King's College London  London UK
South London and Maudsley NHS Foundation Trust  UK
Addictions Department, School of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
South London and Maudsley NHS Foundation Trust, UK
raw_author_name: Mathieu Seynaeve
raw_affiliation_strings: Addictions Department, School of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience King's College London  London UK
Beckley Psytech  Oxford UK
Beckley Psytech, Oxford, UK
Addictions Department, School of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK